CN Stock MarketDetailed Quotes

301333 R&G PharmaStudies

Watchlist
  • 48.70
  • -0.40-0.81%
Market Closed Jan 6 15:00 CST
4.70BMarket Cap38.84P/E (TTM)

R&G PharmaStudies Key Stats

R&G PharmaStudies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 981.518M--
--2024/FY-- / 811.307M--
--2023/FY721.373M / 770.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 981.518M--
--2024/FY-- / 811.307M--
--2023/FY721.373M / 770.000M--
--------
--------

Unlock Free Earnings Estimates

R&G PharmaStudies Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jan 6, 2025

Strong Buy

  • Strong Buy

    63.64%
  • Buy

    36.36%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data